Int J Cancer. 2010 Jun 2.
IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population.
Monday, June 7, 2010
Fudan University, Shanghai_HCC prognostic marker
Int J Cancer. 2010 Jun 2.
Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue.
Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue.
Shanghai Jiao Tong University_HER2 codon 655 for Breast CA??
Breast Cancer Res Treat. 2010 Jun 4. [Epub ahead of print]
Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects
http://www.ncbi.nlm.nih.gov:80/pubmed/20524057
Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects
http://www.ncbi.nlm.nih.gov:80/pubmed/20524057
Wednesday, May 5, 2010
Hopeful radiation therapy for patients: An alternative way of internal radiation

Conventional approaches for certain cancer patients treatment are using drugs or specialized medical instrument with therapeutical means (radiation, heat, ect.) Recently, a targeting molecule (drug) conjugated with a radionuclide offers a personalized treatment for a internal radiation therapy.The most updated status is on phase III in U.S.. An eye-catching news is not merely from scientific and clinical results but on the battleground a business real deal between Bayer and Algeta.
This is a $800M transaction and Algeta received $61M upfront payment. Algeta is a Nordic public company and shares trading at many stock exchange markets. Less than 50 employees work for this company. Even the Eurozone encountered a string of economic drawbacks, Algeta was successful on latest fund raising and appealing Big partner (pharma).
by alveice Team (alveice@gmail.com)
This is a $800M transaction and Algeta received $61M upfront payment. Algeta is a Nordic public company and shares trading at many stock exchange markets. Less than 50 employees work for this company. Even the Eurozone encountered a string of economic drawbacks, Algeta was successful on latest fund raising and appealing Big partner (pharma).
by alveice Team (alveice@gmail.com)
Subscribe to:
Posts (Atom)
alveice Team. Powered by Blogger.